001360.KS
SAMSUNG PHARM. Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,330.00
−0.08%Margins
Gross margin
38.5%
EBITDA margin
-37.4%
EBIT margin
-39.3%
Net margin
-320.9%
FCF margin
-22.8%
-189.8%
Return on equity
-113.3%
Return on assets
-18.5%
Return on invested capital
0.29x
Asset turnover
-KRW 8.8B
Cash from operations
KRW 101
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026